ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury

Abstract Background Traumatic brain injury (TBI) is a significant worldwide public health concern that necessitates attention. Apoptosis signal-regulating kinase 1 (ASK1), a key player in various central nervous system (CNS) diseases, has garnered interest for its potential neuroprotective effects a...

Full description

Bibliographic Details
Main Authors: Shan Meng, Hui Cao, Yichen Huang, Ziyu Shi, Jiaying Li, Yana Wang, Yue Zhang, Shuning Chen, Hong Shi, Yanqin Gao
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-023-02923-6
_version_ 1797451932926738432
author Shan Meng
Hui Cao
Yichen Huang
Ziyu Shi
Jiaying Li
Yana Wang
Yue Zhang
Shuning Chen
Hong Shi
Yanqin Gao
author_facet Shan Meng
Hui Cao
Yichen Huang
Ziyu Shi
Jiaying Li
Yana Wang
Yue Zhang
Shuning Chen
Hong Shi
Yanqin Gao
author_sort Shan Meng
collection DOAJ
description Abstract Background Traumatic brain injury (TBI) is a significant worldwide public health concern that necessitates attention. Apoptosis signal-regulating kinase 1 (ASK1), a key player in various central nervous system (CNS) diseases, has garnered interest for its potential neuroprotective effects against ischemic stroke and epilepsy when deleted. Nonetheless, the specific impact of ASK1 on TBI and its underlying mechanisms remain elusive. Notably, mutation of ATP-binding sites, such as lysine residues, can lead to catalytic inactivation of ASK1. To address these knowledge gaps, we generated transgenic mice harboring a site-specific mutant ASK1 Map3k5-e (K716R), enabling us to assess its effects and elucidate potential underlying mechanisms following TBI. Methods We employed the CRIPR/Cas9 system to generate a transgenic mouse model carrying the ASK1-K716R mutation, aming to investigate the functional implications of this specific mutant. The controlled cortical impact method was utilized to induce TBI. Expression and distribution of ASK1 were detected through Western blotting and immunofluorescence staining, respectively. The ASK1 kinase activity after TBI was detected by a specific ASK1 kinase activity kit. Cerebral microvessels were isolated by gradient centrifugation using dextran. Immunofluorescence staining was performed to evaluate blood–brain barrier (BBB) damage. BBB ultrastructure was visualized using transmission electron microscopy, while the expression levels of endothelial tight junction proteins and ASK1 signaling pathway proteins was detected by Western blotting. To investigate TBI-induced neuroinflammation, we conducted immunofluorescence staining, quantitative real-time polymerase chain reaction (qRT-PCR) and flow cytometry analyses. Additionally, immunofluorescence staining and electrophysiological compound action potentials were conducted to evaluate gray and white matter injury. Finally, sensorimotor function and cognitive function were assessed by a battery of behavioral tests. Results The activity of ASK1-K716R was significantly decreased following TBI. Western blotting confirmed that ASK1-K716R effectively inhibited the phosphorylation of ASK1, JNKs, and p38 in response to TBI. Additionally, ASK1-K716R demonstrated a protective function in maintaining BBB integrity by suppressing ASK1/JNKs activity in endothelial cells, thereby reducing the degradation of tight junction proteins following TBI. Besides, ASK1-K716R effectively suppressed the infiltration of peripheral immune cells into the brain parenchyma, decreased the number of proinflammatory-like microglia/macrophages, increased the number of anti-inflammatory-like microglia/macrophages, and downregulated expression of several proinflammatory factors. Furthermore, ASK1-K716R attenuated white matter injury and improved the nerve conduction function of both myelinated and unmyelinated fibers after TBI. Finally, our findings demonstrated that ASK1-K716R exhibited favorable long-term functional and histological outcomes in the aftermath of TBI. Conclusion ASK1-K716R preserves BBB integrity by inhibiting ASK1/JNKs pathway in endothelial cells, consequently reducing the degradation of tight junction proteins. Additionally, it alleviates early neuroinflammation by inhibiting the infiltration of peripheral immune cells into the brain parenchyma and modulating the polarization of microglia/macrophages. These beneficial effects of ASK1-K716R subsequently result in a reduction in white matter injury and promote the long-term recovery of neurological function following TBI.
first_indexed 2024-03-09T15:01:37Z
format Article
id doaj.art-0068dd6e4f3040a8943a6289cf06cede
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-03-09T15:01:37Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-0068dd6e4f3040a8943a6289cf06cede2023-11-26T13:51:45ZengBMCJournal of Neuroinflammation1742-20942023-10-0120112210.1186/s12974-023-02923-6ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injuryShan Meng0Hui Cao1Yichen Huang2Ziyu Shi3Jiaying Li4Yana Wang5Yue Zhang6Shuning Chen7Hong Shi8Yanqin Gao9State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityDepartment of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji UniversityState Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan UniversityAbstract Background Traumatic brain injury (TBI) is a significant worldwide public health concern that necessitates attention. Apoptosis signal-regulating kinase 1 (ASK1), a key player in various central nervous system (CNS) diseases, has garnered interest for its potential neuroprotective effects against ischemic stroke and epilepsy when deleted. Nonetheless, the specific impact of ASK1 on TBI and its underlying mechanisms remain elusive. Notably, mutation of ATP-binding sites, such as lysine residues, can lead to catalytic inactivation of ASK1. To address these knowledge gaps, we generated transgenic mice harboring a site-specific mutant ASK1 Map3k5-e (K716R), enabling us to assess its effects and elucidate potential underlying mechanisms following TBI. Methods We employed the CRIPR/Cas9 system to generate a transgenic mouse model carrying the ASK1-K716R mutation, aming to investigate the functional implications of this specific mutant. The controlled cortical impact method was utilized to induce TBI. Expression and distribution of ASK1 were detected through Western blotting and immunofluorescence staining, respectively. The ASK1 kinase activity after TBI was detected by a specific ASK1 kinase activity kit. Cerebral microvessels were isolated by gradient centrifugation using dextran. Immunofluorescence staining was performed to evaluate blood–brain barrier (BBB) damage. BBB ultrastructure was visualized using transmission electron microscopy, while the expression levels of endothelial tight junction proteins and ASK1 signaling pathway proteins was detected by Western blotting. To investigate TBI-induced neuroinflammation, we conducted immunofluorescence staining, quantitative real-time polymerase chain reaction (qRT-PCR) and flow cytometry analyses. Additionally, immunofluorescence staining and electrophysiological compound action potentials were conducted to evaluate gray and white matter injury. Finally, sensorimotor function and cognitive function were assessed by a battery of behavioral tests. Results The activity of ASK1-K716R was significantly decreased following TBI. Western blotting confirmed that ASK1-K716R effectively inhibited the phosphorylation of ASK1, JNKs, and p38 in response to TBI. Additionally, ASK1-K716R demonstrated a protective function in maintaining BBB integrity by suppressing ASK1/JNKs activity in endothelial cells, thereby reducing the degradation of tight junction proteins following TBI. Besides, ASK1-K716R effectively suppressed the infiltration of peripheral immune cells into the brain parenchyma, decreased the number of proinflammatory-like microglia/macrophages, increased the number of anti-inflammatory-like microglia/macrophages, and downregulated expression of several proinflammatory factors. Furthermore, ASK1-K716R attenuated white matter injury and improved the nerve conduction function of both myelinated and unmyelinated fibers after TBI. Finally, our findings demonstrated that ASK1-K716R exhibited favorable long-term functional and histological outcomes in the aftermath of TBI. Conclusion ASK1-K716R preserves BBB integrity by inhibiting ASK1/JNKs pathway in endothelial cells, consequently reducing the degradation of tight junction proteins. Additionally, it alleviates early neuroinflammation by inhibiting the infiltration of peripheral immune cells into the brain parenchyma and modulating the polarization of microglia/macrophages. These beneficial effects of ASK1-K716R subsequently result in a reduction in white matter injury and promote the long-term recovery of neurological function following TBI.https://doi.org/10.1186/s12974-023-02923-6ASK1JNK/p38Blood–brain barrier integrityCerebral microvesselNeurobehaviors
spellingShingle Shan Meng
Hui Cao
Yichen Huang
Ziyu Shi
Jiaying Li
Yana Wang
Yue Zhang
Shuning Chen
Hong Shi
Yanqin Gao
ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury
Journal of Neuroinflammation
ASK1
JNK/p38
Blood–brain barrier integrity
Cerebral microvessel
Neurobehaviors
title ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury
title_full ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury
title_fullStr ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury
title_full_unstemmed ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury
title_short ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood–brain barrier integrity after traumatic brain injury
title_sort ask1 k716r reduces neuroinflammation and white matter injury via preserving blood brain barrier integrity after traumatic brain injury
topic ASK1
JNK/p38
Blood–brain barrier integrity
Cerebral microvessel
Neurobehaviors
url https://doi.org/10.1186/s12974-023-02923-6
work_keys_str_mv AT shanmeng ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT huicao ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT yichenhuang ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT ziyushi ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT jiayingli ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT yanawang ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT yuezhang ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT shuningchen ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT hongshi ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury
AT yanqingao ask1k716rreducesneuroinflammationandwhitematterinjuryviapreservingbloodbrainbarrierintegrityaftertraumaticbraininjury